Literature DB >> 1523078

Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.

N J Binkin1, S Salmaso, A E Tozzi, G Scuderi, D Greco, D Greco.   

Abstract

In Italy pertussis vaccination is optional. Fewer than 40% of children younger than 5 years of age are vaccinated, and pertussis remains a common childhood disease. We use data from a variety of sources to examine trends and characteristics of Italian children with pertussis and reasons behind the low vaccine coverage. Approximately 25% of Italian children have experienced clinical pertussis by their fifth birthday. The disease is most severe in those less than 1 year of age; in this group an estimated 1 in 14 cases are hospitalized and 1 in 850 die. The incidence appears to be increasing in the 1- to 4-year age group despite increased vaccination coverage. The low vaccine coverage appears to be caused by the ambivalence of the Italian pediatric community about the vaccine rather than parental concerns about vaccine safety. Legislation is being considered to make pertussis vaccination mandatory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523078

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

2.  Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.

Authors:  G Tormans; E Van Doorslaer; P van Damme; R Clara; H J Schmitt
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

3.  Immunogenicity and safety of a monovalent, multicomponent acellular pertussis vaccine in 15 month-6-year-old German children. Monovalent Acellular Pertussis Vaccine Study Group.

Authors:  K Stehr; U Heininger; R Uhlenbusch; P Angersbach; J Hackell; T Eckhardt
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

Review 4.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Pertussis complications in Germany--3 years of hospital-based surveillance during the introduction of acellular vaccines.

Authors:  P Herzig; C Hartmann; D Fischer; J Weil; R von Kries; G Giani; H Schroten; C H Wirsing von König
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

6.  The distribution over time of costs and social net benefits for pertussis immunization programs.

Authors:  Dorota Zdanowska Girard
Journal:  Int J Health Care Finance Econ       Date:  2009-03-18

Review 7.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

8.  Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy.

Authors:  Geraldo Tadinho Monteverde Spencer; Angela Azzarello; Serena Marchi; Emanuele Montomoli; Edmond J Remarque; Simonetta Viviani; Claudia Maria Trombetta
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

9.  Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian Vaccine Coverage Survey Working Group.

Authors: 
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 10.  Pertussis: a review of disease epidemiology worldwide and in Italy.

Authors:  Giovanni Gabutti; Maria Cristina Rota
Journal:  Int J Environ Res Public Health       Date:  2012-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.